Not directly related to the 5 v longer question but I find it difficult to believe they any such trial would be permitted to exclude vaccinated or previously infected (as EPIC-SR now does) given that that’s got to be a large percentage of the population Paxlovid is being given to in the real world.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.